I like your post… Your absolutely right… we have much more to look forward to. Many more possible catalysts that can happen now and HIV is still there too. Our price should be above our last peak price just on potential. It was at $10 just for HIV BLA acceptance potential back then…
Once the safety aggregate is complete with honors and trials restored with information happening on multiple fronts on these great indications… we should be seeing big changes… or not.
Why… is the question… interesting enough is the ability to overlook Leronlimab’s potential. Yet… nobody can explain well enough for me why we have so little value. It’s a crying shame isn’t it…
Once the safety aggregate is complete with honors and trials restored with information happening on multiple fronts on these great indications… we should be seeing big changes… or not.
Why… is the question… interesting enough is the ability to overlook Leronlimab’s potential. Yet… nobody can explain well enough for me why we have so little value. It’s a crying shame isn’t it…
3